The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase Ib study combining ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in patients with CD20-positive B-cell non-Hodgkin lymphoma (NHL).
Anas Younes
Consultant or Advisory Role - Pharmacyclics (U)
Honoraria - Pharmacyclics
Research Funding - Janssen; Pharmacyclics
Ian Flinn
Consultant or Advisory Role - Janssen (U)
Research Funding - Janssen; Pharmacyclics
Jesus G. Berdeja
Research Funding - Janssen
Jonathan W. Friedberg
Consultant or Advisory Role - Emergent BioSolutions (U); Lilly (U)
Sara Alberti
No relevant relationships to disclose
Catherine Thieblemont
Consultant or Advisory Role - Roche (U); Takeda (U)
Franck Morschhauser
No relevant relationships to disclose
Peter Hellemans
Employment or Leadership Position - Janssen Research & Development
Stock Ownership - Johnson & Johnson
Brett Hall
Employment or Leadership Position - Janssen Research & Development
Stock Ownership - Johnson & Johnson
Johan Smit
Employment or Leadership Position - Janssen Research & Development
Stock Ownership - Johnson & Johnson
Donna Skee
Employment or Leadership Position - Janssen Research & Development
Stock Ownership - Johnson & Johnson
Ronald de Vries
Employment or Leadership Position - Janssen Research & Development
Marija Todorovic
Employment or Leadership Position - Janssen Research & Development
Imran Khan
Employment or Leadership Position - Janssen Research & Development
Stock Ownership - Johnson & Johnson
Nele Fourneau
Employment or Leadership Position - Janssen
Stock Ownership - Johnson & Johnson
Yasuhiro Oki
No relevant relationships to disclose